SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-041355
Filing Date
2023-07-05
Accepted
2023-07-05 20:20:41
Documents
1
Period of Report
2023-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17643
  Complete submission text file 0001209191-23-041355.txt   19016
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENTYX BIOSCIENCES, INC. 332 ENCINITAS BLVD. SUITE 200 ENCINITAS CA 92024
Business Address
Nuss John (Reporting) CIK: 0001874108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 231071683